SynaptixBio reaches hugely significant milestone with selection of candidate drug for clinical trials
- Dr Dan Williams

- Jul 8
- 1 min read
SynaptixBio selects H -ABC antisense oligonucleotide for progression to clinical trials - read about it here >


SynaptixBio selects H -ABC antisense oligonucleotide for progression to clinical trials - read about it here >

Comments